Boehringer implements new disposable technology
German based pharmaceutical company Boehringer Ingelheim has developed and implemented a fully disposable set-up and operational approach for disposable technologies as part of its biopharmaceutical development and manufacturing network.
The disposable set-up is expected to ease process transfers, smooth outsourcing concepts and help Lean-to-Clinic program from gene to drug product in 16 months.
Boehringer Ingelheim's disposable set-up can be operated in the same facility and can also be used for non-GMP process development, according to Boehringer.
Boehringer Ingelheim Biopharmaceuticals Process Science Germany vice president Hitto Kaufmann said, ''We have gathered years of experiences from different single use systems in our expert groups and could therefore form a truly unique single use platform for upstream- and downstream processes."
The platform will be established in Boehringer Ingelheim's mammalian facilities across the globe.
Drug Research Drug Delivery Drug Discovery & Development
Contract Research & Services Clinical Trials Contract Research Contract Services
Automation IT & Software Laboratory Instrumentation
Inward Investment Packaging Regulatory Affairs
This report is a crucial resource for industry executives and anyone looking to access key information about "Shire Plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Buy online from $250